Cited 0 times in
Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.